LATEST NEWS

NBTXR3 Radiation Enhancing Hafnium Oxide Nanoparticles Activated By Radiotherapy In Combination With Anti-PD-1 Therapy: A Phase I Study

For inquiries about our technology, collaborations, clinical trials, or other topics, we encourage you to get in touch with our team.